TELA Bio, Inc.

NasdaqGM TELA

TELA Bio, Inc. Inventory for the quarter ending September 30, 2024: USD 13.60 M

TELA Bio, Inc. Inventory is USD 13.60 M for the quarter ending September 30, 2024, a -5.05% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

TELA Bio, Inc. Inventory for the quarter ending September 30, 2023 was USD 14.32 M, a 18.00% change year over year.
TELA Bio, Inc. Inventory for the quarter ending September 30, 2022 was USD 12.14 M.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

NasdaqGM: TELA

TELA Bio, Inc.

CEO	Mr. Antony Koblish
IPO Date	Nov. 8, 2019
Location	United States
Headquarters	1 Great Valley Parkway
Employees	227
Sector	Materials
Industries Plastics 3D Printing Automotive Parts Biotechnology Composite Materials Containers & Packaging Glass Medical Instruments

Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Key trends

Past 5 years